Ambulatory Cardiac Monitoring Devices Market Scope
Ambulatory monitors are devices that are used to record the electrical activity of the human heart. Ambulatory monitors are used to detecting heart rhythm problems for longer periods of time. These monitor devices help to detect the heart with increased detection time and with more precise results as compared to traditional heart monitors. Ambulatory cardiac monitoring devices are used to assist doctors with irregular cardiac arrhythmias which occur only sporadically and unpredictably. Geographically, North America is leading in terms of revenue part from the region which can be attributed to an increase in government and private funding and a large volume of tests for cardiac diseases is performed especially in this region. Ambulatory Cardiac Monitoring Devices are used to monitor patients with syncope or for infrequent rhythm abnormalities and for long-term monitoring of atrial fibrillation post-ablation. Hence this is the key factor that is triggering the market over the forecast period
The Ambulatory Cardiac Monitoring Devices market study is segmented and major geographies with country level break-up.
The market is expected to grow market in the medical industry. It has rising high blood pressure, obesity, diabetes and more adoption of the monitoring devices are driving the demand for the market. Several companies are operating in the market to provide customers with better offers with various features & unique offerings. The market is a highly fragmented market with the presence of several market players and local players. Which is triggering the market growth over the forecast period
Medtronic (Ireland), Boston Scientific (Unites States),, Abbott Laboratories (Unites States),, GE Healthcare (United States),, BIOTRONIK (Germany),, Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), Micro port scientific corporation (United States), NUUBO Smart Solutions Technologies, SL(Spain), Koninklijke Philips N.V (Netherlands), Welch Allyn – A Hill-Rom Inc.(United States), Spacelabs Healthcare, Inc (United States), Nihon Kohden Corporation (Japan), Fukuda Denshi Co, Ltd( Japan), Biotelemetry, Inc (United States), AliveCor, Inc (Unites States), Biotronik, Inc (Germany), Medronic, Plc (Ireland) and St. Jude Medical, LLC (United States) are some of the key players that are part of study coverage.
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AMA Research has segmented the market of Global Ambulatory Cardiac Monitoring Devices market by Type, Application and Region.
On the basis of geography, the market of Ambulatory Cardiac Monitoring Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
On 18 December 2020 Philips acquire cardiac monitoring specialist biotelemetry. biotelemetry Cardiac monitoring, the company main focused was on the diagnosis and monitoring of heart rhythm disorder, and On 21 January 2021 Boston Scientific acquires cardiac sensor maker preventive solutions. Preventive Solutions is a remote patient monitoring device and it has acquired by medical technology firm Boston Scientific for USD 925 million, with as much as USD300 million
On 23 November 2020 Vital Connect launches Vital Patch RTM which is the extension for Holter monitoring, and On 8th October 2020, Medtronic launches world-first pacemaker which Can Communicate directly with Patients via smartphones and tablets as well as another device
- The wireless ECG monitors can be used for the continuous monitoring of patients suffering from CVD and for the detection of problems when they are usually easier to treat while avoiding life-threatening and expensive emergency admissions.
- It helps to record patient heart rhythm and blood flow regulation in the human body
- Ambulatory monitors are devices is used to record the electrical activity in the human heart.
- The sampling period is usually for a short period of time which to allow the capture of infrequent arrhythmia.
- large amount skilled labour is required
Key Target AudienceOEM (Original Equipment Manufacturer), Equipment Supplier, Regulatory Authorities, New Entrants/Investors, Strategic Business Planners, Governments and End-Use Industry
Frequently Asked Questions (FAQ):
1. Is it possible to have certain customization in the study?
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a study that suits your business objectives.
2. How big is the Ambulatory Cardiac Monitoring Devices Market?
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2026.